Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Stock Option Plan [Amended 2001]

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Stock Option Plan [Amended 2001]

Entities:

Lynx Therapeutics, Inc.

Date:

2001

Size:

Preview shows 4KB of 37KB total

Price:

$40

ID:

#279361

 

 

► Plans ► Option ► Stock Option Plans
► Biotech & Drugs ► Medicinal Chemicals & Botanical Products

 

 

Start of Preview


                             LYNX THERAPEUTICS, INC.


1992 STOCK OPTION PLAN

ADOPTED JULY 1, 1992
LAST AMENDED BY THE BOARD ON MARCH 1, 2001
LAST APPROVED BY STOCKHOLDERS ON MAY 24, 2001
TERMINATION DATE: MARCH 11, 2006

PURPOSES.

ELIGIBLE OPTION RECIPIENTS. The persons eligible to receive Options are
the Employees, Directors and Consultants of the Company and its Affiliates.

AVAILABLE OPTIONS. The purpose of the Plan is to provide a means by which
eligible recipients of Options may be given an opportunity to benefit from
increases in value of the Common Stock through the granting of the following
Options: (i) Incentive Stock Options, and (ii) Nonstatutory Stock Options.

GENERAL PURPOSE. The Company, by means of the Plan, seeks to retain the
services of the group of persons eligible to receive Options, to secure and
retain the services of new members of this group and to provide incentives for
such persons to exert maximum efforts for the success of the Company and its
Affiliates.

DEFINITIONS.

"AFFILIATE" means any parent corporation or subsidiary corporation of the
Company, whether now or hereafter existing, as those terms are defined in
Sections 424(e) and (f), respectively, of the Code.

"BOARD" means the Board of Directors of the Company.

"CODE" means the Internal Revenue Code of 1986, as amended.

"COMMITTEE" means a Committee appointed by the Board in accordance with
subsection 3(c).

"COMMON STOCK" means the common stock of the Company.

"COMPANY" means Lynx Therapeutics, Inc., a Delaware corporation.

"CONSULTANT" means any person, including an advisor, (1) engaged by the
Company or an Affiliate to render consulting or advisory services and who is
compensated for such services or (2) who is a member of the Board of Directors
of an Affiliate. However, the term "Consultant" shall not include either
Directors of the Company who are not compensated by the Company for their
services as Directors or Directors of the Company who are merely paid a
director's fee by the Company for their services as Directors.



1.
{PAGE} 3

"CONTINUOUS SERVICE" means that the Optionholder's service with the
Company or an Affiliate, whether as an Employee, Director or Consultant, is not
interrupted or terminated. The Optionholder's Continuous Service shall not be
deemed to have terminated merely because of a change in the capacity in which
the Optionholder renders service to the Company or an Affiliate as an Employee,
Consultant or Director or a change in the entity for which the Optionholder
renders such service, provided that there is no interruption or termination of
the Optionholder's Continuous Service. For example, a change in status from an
Employee of the Company to a Consultant of an Affiliate or a Director of the
Company will not constitute an interruption of Continuous Service. The Board or
the chief executive officer of the Company, in that party's sole discretion, may
determine whether Continuous Service shall be considered interrupted in the case
of any leave of absence approved by that party, including sick leave, military

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC